Clinical Therapeutics/New Technology-Insulins

Clinical Therapeutics/New Technology-Insulins

You have access
Use of Premixed Insulin, Metformin, and a Glucagon-Like Peptide 1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes
Nicole Ehrhardt, Sasan Fazeli, Sanjana Rao, Richard Amdur

Diabetes Spectrum May 2020, 33 (2) 182-189; DOI: 10.2337/ds19-0025
You have access
Low-Carbohydrate and Very-Low-Carbohydrate Diets in Patients With Diabetes
Jennifer D. Merrill, Diana Soliman, Nitya Kumar, Sooyoung Lim, Afreen I. Shariff, William S. Yancy

Diabetes Spectrum May 2020, 33 (2) 133-142; DOI: 10.2337/ds19-0070
You have access
A Behavioral Perspective of Therapeutic Inertia: A Look at the Transition to Insulin Therapy
Susan J. Guzman

Diabetes Spectrum Feb 2020, 33 (1) 38-43; DOI: 10.2337/ds19-0024
Open Access
Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units
Osama Hamdy, Robert A. Gabbay

Diabetes Care May 2020, dc200944; DOI: 10.2337/dc20-0944
Open Access
Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S.
Timothy J. Garrett, Philip Atkinson, Eoin P. Quinlivan, Lynn Ang, Irl B. Hirsch, Lori Laffel, Massimo Pietropaolo, Michael J. Haller, Mark A. Atkinson

Diabetes Care Jun 2020, 43 (6) 1360-1362; DOI: 10.2337/dc19-1941
You have access
A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial
Francisco J. Pasquel, M. Cecilia Lansang, Ameer Khowaja, M. Agustina Urrutia, Saumeth Cardona, Bonnie Albury, Rodolfo J. Galindo, Maya Fayfman, Georgia Davis, Alexandra Migdal, Priyathama Vellanki, Limin Peng, Guillermo E. Umpierrez

Diabetes Care Jun 2020, 43 (6) 1242-1248; DOI: 10.2337/dc19-1940
Open Access
A Tribute to Robert Roy Henry—The Classic “Academic Triple Threat”: Accomplished Researcher, Inspiring Teacher, and Compassionate Clinician
Steven Edelman, Jerrold Olefsky, Sunder Mudaliar, Ted Ciaraldi, Alain Baron

Diabetes Care Mar 2020, 43 (3) 522-525; DOI: 10.2337/dci19-0075
You have access
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9)
Wendy S. Lane, Elena Favaro, Naveen Rathor, Hak C. Jang, Maiken I.S. Kjærsgaard, Alejandra Oviedo, Ludger Rose, Peter Senior, Giorgio Sesti, Alfonso Soto Gonzalez, Edward Franek

Diabetes Care Mar 2020, dc192232; DOI: 10.2337/dc19-2232
You have access
Treatment Patterns, Adherence, and Persistence Associated With Human Regular U-500 Insulin: A Real-World Evidence Study
Jieling Chen, Christi Y. Kao, Xuanyao He, Ludi Fan, Jeffrey A. Jackson, Rattan Juneja

Diabetes Spectrum Mar 2020, ds190060; DOI: 10.2337/ds19-0060
Open Access
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Deborah J. Wexler, Heidi Krause-Steinrauf, Jill P. Crandall, Hermes J. Florez, Sophia H. Hox, Alexander Kuhn, Ajay Sood, Chantal Underkofler, Vanita R. Aroda, the GRADE Research Group

Diabetes Care Nov 2019, 42 (11) 2098-2107; DOI: 10.2337/dc19-0901

Main menu

User menu

Search

Clinical Therapeutics/New Technology-Insulins

Pages

Navigate

More Information

Other ADA Resources